119 related articles for article (PubMed ID: 3220104)
1. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
Cryz SJ; Cross AS; Sadoff GC; Que JU
Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
[TBL] [Abstract][Full Text] [Related]
2. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Sadoff JC; Ohman D; Fürer E
J Lab Clin Med; 1988 Jun; 111(6):701-7. PubMed ID: 3131471
[TBL] [Abstract][Full Text] [Related]
4. Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.
Roberton DM; Björkander J; Henrichsen J; Söderström T; Hanson LA
Clin Exp Immunol; 1989 Feb; 75(2):201-5. PubMed ID: 2702775
[TBL] [Abstract][Full Text] [Related]
5. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
Lue C; Tarkowski A; Mestecky J
J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the subclass of IgG antibody to type 3 pneumococcal polysaccharide during childhood.
Schatz DA; Barrett DJ
Clin Exp Immunol; 1987 Nov; 70(2):449-55. PubMed ID: 3427829
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
Kuijpers TW; Weening RS; Out TA
Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
[TBL] [Abstract][Full Text] [Related]
8. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
9. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide.
Shackelford PG; Granoff DM; Nelson SJ; Scott MG; Smith DS; Nahm MH
J Immunol; 1987 Jan; 138(2):587-92. PubMed ID: 3491852
[TBL] [Abstract][Full Text] [Related]
10. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
11. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
[TBL] [Abstract][Full Text] [Related]
13. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
Barrett DJ; Ayoub EM
Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
[TBL] [Abstract][Full Text] [Related]
14. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.
Weinberg GA; Granoff DM; Nahm MH; Shackelford PG
J Immunol; 1986 Jun; 136(11):4232-6. PubMed ID: 3486228
[TBL] [Abstract][Full Text] [Related]
15. Isotype concentrations of human antibodies to group A meningococcal polysaccharide.
Rautonen N; Pelkonen J; Sipinen S; Käyhty H; Mäkelä O
J Immunol; 1986 Oct; 137(8):2670-5. PubMed ID: 3093581
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue.
Ogawa T; Tarkowski A; McGhee ML; Moldoveanu Z; Mestecky J; Hirsch HZ; Koopman WJ; Hamada S; McGhee JR; Kiyono H
J Immunol; 1989 Feb; 142(4):1150-8. PubMed ID: 2644350
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to pneumococcal vaccine in splenectomized children.
Pedersen FK
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.
Mascart-Lemone F; Gérard M; Libin M; Crusiaux A; Franchioly P; Lambrechts A; Goldman M; Clumeck N
J Infect Dis; 1995 Nov; 172(5):1253-60. PubMed ID: 7594661
[TBL] [Abstract][Full Text] [Related]
20. Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman.
McElroy PJ; Henderson FI; Brown DL
Clin Exp Immunol; 1989 Dec; 78(3):402-5. PubMed ID: 2612052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
